INTRODUCTION
Tooth avulsion is one of the most complex modalities of traumatic dental injuries, which corresponds to 0.5%-16% of all traumatic accidents of permanent dentition. [1, 2] It is commonly associated with serious complications due to severe damage to the periodontal ligament (PDL). [3] In spite of all clinical efforts which have been made to avoid the root resorptions, the frequency PDL cells on the survival of the exarticulated teeth, there are no promising outcomes of the current treatment protocols. [1] [2] [3] [4] Histologically, after replantation of a traumatized tooth, a coagulum is formed which initiates the wound healing procedure, [2] a complex mechanism compiling of four distinct phases: homeostasis, inflammation, proliferation, and remodeling [2, 5] All of these stages are regulated and controlled by cellular and humoral elements, starting with the impact of platelets in the homeostasis process. [2, 6] Previous researches revealed the significant role of various growth factors and cytokines associated with wound repair progression. [7] [8] [9] Released growth factors bind to the receptors of target cells (fibroblasts, osteoblasts, mesenchymal stem cells) and activate intracellular signals leading to cellular proliferation, collagen synthesis, and matrix formation as essential components of the wound healing. [2, 10, 11] In tissue injuries with blood vessel disruption, platelets adhere to the exposed collagen proteins and initiate the secretion of numerous mediators. [2, 10, 12] Growth factors released by platelets such as platelet-derived growth factors (PDGFs) and transforming growth factor-β (TGF-β), as well as insulin-like growth factor-I, are mitogenic proteins associated with collagen synthesis, bone formation, and early wound closure. [2, 10] According to the outstanding and crucial impacts of growth factors associated with wound repair, there is currently a great deal of interest in implementing potential origins of these elements either recombinant growth mediators or factors with autogenous origin such as platelet-rich plasma (PRP). [13] PRP is defined as a portion of high concentrated platelets (3-5-fold) in a small volume of plasma. [3, 14] Accumulation of platelets in PRP results in increased levels of growth factors for a longer period compared to the whole blood clots of similar volumes. [15] [16] [17] Thus, applying PRP in patients undergoing osseous or periodontal regeneration is recommended on the premise that the large population of platelets in PRP releases huge amounts of essential factors, and it is biologically safe and inexpensive compared to recombinant allogeneic or xenogeneic preparations. [2, 13, 16, 18] However, although promising results are reported by many in vivo or in vitro investigations on bone or PDL repair, some others demonstrate a retardation of tissue regeneration due to PRP treatment. One of the reasons explaining the disparity of reported findings may be due to the different PRP concentrations and thus various amount of growth factors and diverse target cells in the above-mentioned studies, [2] which led to conflicting recommendations. [13, 14, [19] [20] [21] Therefore, the purpose of this in vitro study was to examine the impact of different PRP concentrations on the proliferation of undifferentiated PDL cells.
MATERIALS AND METHODS
This research was approved by the Institutional Review Board and Ethics Committee of Shahed University (4/418), Tehran, Iran, and informed consent was obtained from the adult contributor and the parents of the minor precipitant.
Cell culture
Human PDL cells were obtained from two clinically sound premolars extracted for orthodontic reasons from a 14-year-old systematically and periodontally healthy patient.
The freshly extracted teeth were immersed in Dulbecco's modified Eagle medium (DMEM; Gibco, Glasgow, UK), supplemented with 1% penicillin/ streptomycin, 1% gentamycin, 12% fetal bovine serum (FBS), and 0.5% amphotericin B. Following rinsing with phosphate-buffered saline for residual blood elimination, PDL tissues were collected from the mid-third of the teeth root with a #15 scalpel under sterile conditions. The detached tissues were transferred into 25 cm 2 culture dishes (Nunc, Roskilde, Denmark). The explants were incubated with DMEM, 12% FBS, penicillin 50 µg/ml, and streptomycin 50 µg/ml at 37°C in the presence of 5% of CO 2 in air for 3 weeks. The culture medium was renewed every 3 days until cells reached confluence. The cells from passages 3 to 6 were used in this study. Cells were seeded in five 24-well plates at a density of 5 × 10 4 cells/well, corresponding to each of the experimental time courses (1, 2, 3, 4, and 7 days). After 24 h, each group of cells was exposed to PRP in one of the examined concentrations (0.1%, 5%, and 50%). No culture medium and FBS 12% served as negative and positive controls, respectively.
Platelet-rich plasma preparation
PRP was collected and prepared immediately before application on the cultured cells. Twenty milliliters venous blood from a healthy donor was collected in acid-citrate-dextrose solution formula A collection tube (BD, United States). The whole blood was initially centrifuged at 2400 rpm for 10 min to separate red blood cell (RBC) portion from PRP and platelet-poor plasma. The upper layer of RBC fraction and PRP portion were removed and centrifuged again at 3600 rpm for 15 min, and PRP was extracted in a plain collection tube (BD, United States). [22] PRP was activated by adding calcium chloride (CaCl 2 ) and immediately diluted with DMEM, resulting in concentrations of 0.1%, 5%, and 50%.
3-(4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium bromide (cell viability) assay
The 3-(4,5-dimethylthiazol-2-yl)-2,5-dipheny ltetrazolium bromide (MTT) assay was conducted to assess the cell viability and proliferation [23] after each of the experimental time periods in all of the treatment mediums. Cells were incubated with 50 µl of MTT solution (Sigma-Aldrich, USA) for 4 h at 37°C. The MTT media were then discarded and formazan crystals were dissolved by adding 50 µl of dimethyl sulfoxide (Sigma-Aldrich, USA) to each well. [23] The spectrophotometric absorbance of each sample recorded at 570 nm in an ELISA reader (Anthos Labtec Instruments, Austria) was reported as optical density (OD). [23, 24] The mean cell viability was expressed as the percentage of the mean experimental OD values to the values of the control (OD value of the control at the time = 0 was 0.89).
Statistical analysis
One-way ANOVA and post hoc Tukey's test were used to evaluate differences of the mean cell viability values among various treatments. A P < 0.05 was considered statistically significant.
RESULTS
In the present study, the effect of various concentrations of PRP and two groups without PRP (control groups) on the cells vitality at five time intervals was assessed using an MTT method.
The average platelet count of the donor was 282,000 platelets/µl, while the mean platelet count of the PRP preparation was 1,194,000 platelets/µl.
The mean viability of different PRP and control groups on days 1, 2, 3, 4, and 7 is demonstrated in Table 1 , revealing a significant difference among the samples at various time intervals (P < 0.001).
All groups showed a progressive proliferation during the first 72 h, with their peak on the 3 rd day. However, afterward, a decrease in cell vitality occurred on the 4 th and 7 th days in all experimental and control groups [ Figure 1 ].
No significant difference was found between the positive control and 0.1% PRP during the first 3 days (P > 0.05). We observed the most promising results during the 72 h with the 5% PRP concentration. Although in comparison with 12% FBS group, this was insignificant on the 1 st day (P > 0.05), a statically significant difference on the 2 nd and 3 rd days was seen (P < 0.05 and P < 0.001, respectively). A significant difference between the 5% and 0.1% PRP groups was found during the 3 rd and 4 th days [ Table 2 ].
As revealed in Table 1 , 50% PRP decreased the proliferation rate during all the five time intervals. This was even significant after the 1 st day compared with control group without 12% FBS (P < 0.05), presenting a suppressing effect on the cell proliferation [ Table 2 ].
DISCUSSION
During the first step of the PDL regeneration, a temporary matrix of fibrinogen, fibronectin, and fibrin is formed at the site of the injury to minimize cell loss. Platelet-released growth factors, particularly PDGF-β, promote cell proliferation, migration, adherence, and their spreading on the extracellular matrix. [2, 14, 21] PRP has been introduced as an autologous source of platelets in different aspects of wound healing in dentistry, delivering increased levels of growth factors. [15] However, due to different preparation techniques, various cell types, and different platelet concentrations, there is variety of recommendations concerning its usage. [10, 15, 20, 21] A concentration of 1,000,000 platelets/µl has been recommended as the working definition of PRP. Since the normal range of platelets in the whole blood of healthy individuals varies from 140,000 to 400,000 platelets/µl, this means a 3-5-fold increase over the baseline concentration. [15, 16] We found 282,000 and 194,000 platelets/µl in whole blood and PRP sample, respectively, demonstrating a 4.2-fold enrichment, which was in accordance with previous literature. [15, 16, 25] At present, we found that PRP enhanced PDL cell proliferation, yet in a dose-dependent manner, with 5% concentration being most effective. A dose-related response was also observed by Arikan et al., however, with different activation methods and PRP concentrations. They have also delivered PRP into the cell cultures for several times; conversely, in our research, a onetime PRP delivering was applied to mimic the clinical conditions. [5] We found that both 0.1% and 5% PRP concentrations encouraged cellular proliferation although 5% PRP significantly had a greater stimulating impact. The 50% concentration adversely affected cell vitality.
Creeper et al. also reported a cytotoxic effect in implementing maximum PRP concentrations (100%); however, they suggested 50% concentration as the most proliferative PRP enrichment for PDL cells. [26] Choi et al. examined the effect of PRP in various concentrations on the bone formation within the PRP-treated bone grafts. They suggested that a dilution of PRP to a level of 0.5%-5% would stimulate osteoblastic proliferation and might act as a mitogen on alveolar bone cells. [23] Our results revealed an enhancement of cellular proliferation when PDL cells were cultured in a medium supplemented with low PRP density. This finding may be explained by the fact that as cell surface receptors are completely invaded by a specific growth factor, the remaining unbounded growth mediators have no additional impact; on the contrary, in high concentrations, an inhibitory effect on cell functions may be induced. [17] Han et al. reported that the most stimulatory effect of PRP on PDL cells may be exerted by a concentration of 50-100 ng/ml of TGF-β. [27] Thus, the optimal concentration of the platelets should be selected according to the target cells as a determinant element. [17] As stated previously, more than 2/3 of the essential growth factors are released within 10 min and almost [16, 26] Nevertheless, we found a significant reduction in all cultured groups after this time. It may be due to the fact that following the high proliferation rate during the first 72 h, the number of cells is increased leading to a shortage of nutritional sources and aggregation of waste materials. [5] PRP preparation protocols rely on a variety of activators such as bovine or autologous thrombin or CaCl 2 . All of them initiate the clotting cascade and precipitation of the fibrin scaffold. However, bovine thrombin has demonstrated several side effects in human or animal investigations. Hemorrhage, thrombosis, raised antibody levels against coagulation proteins are some of the adverse effects of exogenous thrombin. [15] As no side effects were reported in association with CaCl 2 as PRP activator, we have preferred its usage. CaCl 2 leads to the conversion of prothrombin to thrombin as the first step of clot formation and healing process. [15, 28, 29] One of the complications with the clinical use of PRP in treating traumatized teeth is the young age of injured patients ranging mostly from 7 to 9 years, with a generally still low cooperation for being subjected to blood drawing procedure. [2] However, performing venipuncture by a trained surgeon and using behavior management techniques may decrease the inconvenience of the treatment.
We believe that final prognosis of a traumatized tooth particularly suffered from exarticulation is affected by multiple influencing factors other than those acting on in vitro settings, changing the environment of PDL regeneration. Thus, we suggest further in vivo investigations of PRP-treated avulsed teeth with follow-up radiographs to evaluate the clinical significance of these results.
CONCLUSIONS
Under the condition of this in vitro study, it can be concluded that:
1. Different PRP concentrations may influence PDL regeneration 2. The vitality and proliferation of PDL cells are stimulated by low concentrations of PRP (5%) and are suppressed by high concentrations (50%), suggesting a dose-related response.
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